Interesting looking at PME doing another buyback. I think it's only up to around $1.5m? I think the SP is pretty well prices at $90 let alone $110? Good luck to holders though. The question for me in these circumstances is whether that money could be utilised better in increased staff, technology R&D etc given the SP is pretty healthy any way. I think CUV feels their cash could be used differently at this time - of course as we know they are tending to accumulate and have been conservative. I think a buyback should have a more significant effect at CUV vs PME - it seemingly stopped the slide at PME. PW finally indicated it might be possible but who knows what plans they have for the money - there should be a bigger spend on trials and regulatory affairs along with the OTC's in the next 12 months. Maybe more clarity on the use of funds tomorrow? Bit of relief I guess over at NEU. Will regulators take action if the short report is unfounded? I doubt it.
- Forums
- ASX - By Stock
- CUV
- Disc Medicine - Best comparison stock to Clinuvel
Disc Medicine - Best comparison stock to Clinuvel, page-40
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.49 |
Change
-0.130(0.83%) |
Mkt cap ! $772.7M |
Open | High | Low | Value | Volume |
$15.60 | $15.75 | $15.39 | $558.8K | 36.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 135 | $15.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.50 | 128 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 135 | 15.480 |
4 | 385 | 15.470 |
6 | 246 | 15.460 |
5 | 720 | 15.450 |
4 | 417 | 15.440 |
Price($) | Vol. | No. |
---|---|---|
15.500 | 128 | 3 |
15.510 | 169 | 2 |
15.520 | 248 | 3 |
15.530 | 183 | 2 |
15.540 | 245 | 3 |
Last trade - 14.39pm 16/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |